NCT05230238 (PGS) is a NA clinical trial of Pituitary gland stimulation in Oncology Pain, sponsored by Leiden University Medical Center.

Who is sponsoring NCT05230238?

NCT05230238 is sponsored by Leiden University Medical Center.

What drugs are being tested in NCT05230238?

Interventions in NCT05230238: Pituitary gland stimulation.

What condition does NCT05230238 study?

NCT05230238 studies Oncology Pain.

Is NCT05230238 still recruiting?

NCT05230238 is currently status unknown. Last updated 10 March 2023.

Last reviewed 2023-03-10 · How we verify

NCT05230238: PGS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pituitary Gland Stimulation for Cancer Pain Relief

Status unknown NA Last updated 10 March 2023

What this trial tests

NA trial testing Pituitary gland stimulation in Oncology Pain in 10 participants. Status unknown.

Timeline

12 October 2021

Primary endpoint
1 January 2024

1 January 2024

Quick facts

Lead sponsor	Leiden University Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	12 October 2021
Primary completion	1 January 2024
Estimated completion	1 January 2024
Sites	1 location across Netherlands

Drugs / interventions tested

Pituitary gland stimulation

Conditions studied

Oncology Pain — all drugs for Oncology Pain →

Sponsor

Leiden University Medical Center

Who can join

18 and older, any sex, with Oncology Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients will undergo an implantation of an extradural pituitary surface electrode in the pituitary fossa. The electrode will be attached to a neurostimulator via which the patient will receive up to 8 (patient requested) stimulations per day.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Oncology Pain

Currently open trials in the same condition.

NCT07262632 — Developing a Multimodal Cancer Pain Database to Support AI-Based Automatic Pain Assessment · recruiting
NCT06884332 — Spinal Palliation in Irradiation for Neoplastic Analgesia and Life Quality · NA · recruiting

Other Leiden University Medical Center trials

Trials by the same sponsor.

NCT07312565 — Occurrence of Abdominal Aortic Aneurysms in Patients With Aneurysmal Subarachnoid Hemorrhage · not yet recruiting
NCT07090343 — Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement · Phase 3 · not yet recruiting
NCT07498738 — Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions · NA · not yet recruiting
NCT06545292 — Microsampling for Therapeutic Drug Monitoring of Oral Oncolytics in Oncology Patients · NA · recruiting
NCT07021495 — SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05230238 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Leiden University Medical Center
Last refreshed: 10 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05230238.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing